Peptide Synthesis Market Size, Insights Forecast, Growth, Trends 2024-2033

Overview and Scope

Peptide synthesis refers to the laboratory process of producing peptides, which are compounds that are short chains of amino acids linked together by chemical bonds. These synthesized peptides have various applications in research, drug development, and medical diagnostics to generate precise sequences that mimic epitopes within particular protein domains.

Sizing and Forecast

The peptide synthesis market size has grown strongly in recent years. It will grow from $5.22 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization..

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.05 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rapid growth in therapeutic peptides, increasing demand for customized peptides, growing role in drug discovery and development, focus on peptide libraries for screening.. Major trends in the forecast period include development of peptide mimetics, adoption of novel amino acid derivatives, peptide cyclization techniques, innovations in solid-phase peptide synthesis (spps), utilization of click chemistry..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Segmentation & Regional Insights

The peptide synthesis market covered in this report is segmented –

1) By Product And Service: Reagents, Equipment, Services
2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology
3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes

North America was the largest region in the peptide synthesis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

Major Driver Impacting Market Growth

Growing chronic diseases are expected to propel the growth of the peptide synthesis market going forward. Chronic diseases refer to illnesses or non-communicable diseases (NCDs) that are long-term health conditions that persist over an extended period and often progress gradually. Peptide synthesis can be used for chronic diseases as some peptides exert anti-inflammatory and antioxidant activity, which could aid in the prevention of chronic diseases, including cardiovascular diseases. Peptides can address the fundamental causes of chronic disease by targeting particular cellular processes and signaling pathways, opening up novel therapeutic and management options. For instance, in August 2023, according to the data published by the British Heart Foundation, a UK-based non-profit organization, the number of deaths caused by coronary heart disease in the UK increased to 65,579 in 2021, compared with 64,170 in 2020. Therefore, the growing number of chronic diseases is driving the growth of the peptide synthesis market.

Key Industry Players

Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

The peptide synthesis market report table of contents includes:

1. Executive Summary
2. Peptide Synthesis Market Characteristics
3. Peptide Synthesis Market Trends And Strategies
4. Peptide Synthesis Market – Macro Economic Scenario
5. Global Peptide Synthesis Market Size and Growth
.
.
.
32. Global Peptide Synthesis Market Competitive Benchmarking
33. Global Peptide Synthesis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Peptide Synthesis Market
35. Peptide Synthesis Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model